The FDA approval means this compound has an established clinical safety profile and peer-reviewed dosing data that most research peptides lack
It serves multiple critical functions in hepatic health, acting as both a direct antioxidant and a cofactor for various detoxification enzymes
The experimental protocol consists of taking 1 g of PL or LC 90 and 60 min before the experiment
This may be related to decreased renal function, leading to reduced excretion of TMAO, along with alterations in the composition and metabolic function of the gut microbiota
However, more recent findings suggest NAD+ therapy might work even better when paired with a compound called 5-Amino-1MQ
It suggests that the benefits in terms of MACE, hospitalization for heart failure, and progression of chronic kidney disease (composite outcome) from SGLT2is occur independently of the use of GLP1-RAs